<DOC>
	<DOCNO>NCT01236768</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety low dose transdermal contraceptive delivery system contain ethinyl estradiol levonorgestrel .</brief_summary>
	<brief_title>Transdermal Contraceptive Delivery System ( TCDS ) , Also Known AG200-15 Patch Arm</brief_title>
	<detailed_description>Comparative evaluation AG200-15 versus OC regard safety , contraceptive efficacy , hormone related adverse event , lipid profile , cycle control ( bleed pattern ) , subject compliance serum concentration EE LNG . To evaluate TCDS wearability ( include adhesion ) .</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Hormonal</mesh_term>
	<criteria>sexually active woman request contraception Regular menses every 24 35 day In good general health , confirm medical history , physical ( include gynecologic examination adn screen laboratory value Known suspect pregnancy Lactating woman Significant skin reaction transdermal preparation sensitivity surgical / medical tape Any disease may worsen hormonal treatment ( cardiovascular , liver , metabolic ) Use contraceptive method study medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Contraceptive</keyword>
</DOC>